Molecular characterization of hepatocellular carcinoma in Mongolia delineates unique genomic features
Marc Puigvehí(Parc de Salut), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Carla Montironi(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Daniela Sia(Icahn School of Medicine at Mount Sinai), Sofiá Pérez-del-Pulgar, Chinbold Enkhbold(National Center for Communicable Diseases), Andrew Uzilov(Sema4 (United States)), Thais Leonel(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Amankyeldi Yerbolat(Mongolian National University), Xavier Forns(Hospital Clínic de Barcelona), Erdenebileg Taivanbaatar, Mireia Garciá-López, Augusto Villanueva(NYU Langone Health), Vincenzo Orlando, Miguel Torres‐Martín(Tisch Hospital), Wei Qiang Leow(SingHealth), Jigjidsuren Chinburen, Swan N. Thung(Icahn School of Medicine at Mount Sinai), Huan Wang(Chengdu Military General Hospital), Miho Maeda, Geniś Campreciós, Sasan Roayaie(White Plains Hospital), Sara Torrecilla(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas)
Cited by 0
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k